Human Growth Hormone Market Report 2026

Human Growth Hormone Market Overview

• Human Growth Hormone market size has reached to $5.18 billion in 2025 • Expected to grow to $7.87 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: Rise In Aging Population Fueling The Growth Of The Market Due To Increasing Age-Related Healthcare Needs • Market Trend: Innovative Long-Acting Growth Hormone Treatment Gains FDA Approval Enhancing Pediatric Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Human Growth Hormone Market?

Human growth hormone (HGH) is a peptide hormone naturally produced by the pituitary gland that is crucial for stimulating growth, cell reproduction, and tissue regeneration throughout the human body. It is used in medical treatments for growth hormone deficiency, fostering muscle development, and addressing age-related concerns such as muscle wasting and bone density decline. The main product types of human growth hormone are liquid, and powder. Human growth hormones available in liquid form are typically in a solution or suspension, ready for immediate consumption or injection. The various brands include norditropin, genotropin, humatrope, saizen, omnitrope, skytrofa, others that are used through various routes of administration such as oral, intravenous, intramuscular, subcutaneous. These are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies, and specialty pharmacies. These are used in various applications such as growth hormone (GH) deficiency, adult GH deficiency, pediatric Gh deficiency, turner syndrome, idiopathic short stature, prader-willi syndrome, small for gestational age, and others.

What Is The Human Growth Hormone Market Growth Forecast?

The human growth hormone market size is expected to see strong growth in the next few years. It will grow to $7.87 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing demand for long-acting growth hormone therapies, rising prevalence of adult growth hormone deficiency, growing focus on personalized endocrine treatments, expansion of specialty pharmacy distribution, increasing investment in hormone therapy research. Major trends in the forecast period include increasing demand for growth hormone deficiency treatments, rising adoption of long-acting growth hormone formulations, growing use of hgh in pediatric endocrinology, expansion of recombinant growth hormone therapies, increasing focus on patient adherence and convenient administration.

Global Human Growth Hormone Market Segmentation

1) By Product: Liquid, Powder 2) By Brand: Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Other Brands 3) By Route Of Administration: Intramuscular, Subcutaneous 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Specialty Pharmacy 5) By Application: Growth Hormone (GH) Deficiency, Adult Growth Hormone (GH) Deficiency, Pediatric Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Other Applications Subsegments: 1) By Liquid: Pre-Filled Liquid Syringes, Vials Of Liquid Growth Hormone 2) By Powder: Reconstitutable Powder, Freeze-Dried Powder

What Are The Drivers Of The Human Growth Hormone Market?

The rise in aging population is expected to drive the growth of the human growth hormone market going forward. An aging population refers to a growing proportion of older individuals within a society due to increased life expectancy and declining birth rates. The aging population is increasing due to advancements in healthcare that have extended life expectancy. Human growth hormone is used by the aging population to help address age-related muscle loss, reduced energy, and metabolic decline under medical supervision. For instance, in January 2024, according to the Population Reference Bureau, a US-based non-profit organization, reported that the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. As a result, this age group’s proportion of the total U.S. population will grow from 17% to 23% during this period. Therefore, the rise in aging population is driving the growth of the human growth hormone industry. The rising healthcare expenditure is expected to propel the growth of the human growth hormone market going forward. Healthcare expenditure refers to the total spending on health services, products, and interventions aimed at improving and maintaining health. Human growth hormone (HGH) therapy offers a unique approach to reducing healthcare expenditure by addressing underlying health issues that drive long-term costs, enhancing recovery and quality of life, and potentially mitigating the onset of costly chronic conditions. For instance, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, the rising healthcare expenditure drives the human growth hormone industry.

Key Players In The Global Human Growth Hormone Market

Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics

Global Human Growth Hormone Market Trends and Insights

Major companies operating in the human growth hormone market are increasing their focus on drug development and its approvals to advance the medication offering and to provide better treatment solution. Drug development is a complex and rigorous process that involves multiple stages to ensure a new drug's safety, efficacy, and quality before it reaches the market. For instance, in June 2023, Pfizer Inc., a US-based biopharmaceutical company, and OPKO Health Inc., a US-based biopharmaceutical and diagnostics company, announced the approval of NGENLA (somatrogon-ghla) by the Food and Drug Administration (FDA). This treatment offers a more convenient dosing regimen and improves patient adherence compared to daily injections. It gives children with growth hormone deficiency the option to reduce the frequency of injections from daily to once a week. The FDA approval was supported by a Phase 3 study showing NGENLA's non-inferiority compared to once-daily somatropin, with a safety profile comparable to somatropin.

Regional Outlook

North America was the largest region in the human growth hormone market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Human Growth Hormone Market?

The human growth hormone market consists of sales of sustained-release formulations, combination therapies, biosimilar versions, long-acting formulations, pediatric-specific formulations, and personalized dosing regimens. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Human Growth Hormone Market Report 2026?

The human growth hormone market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the human growth hormone industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.